AdvisorShares Alpha DNA Equity Sentiment ETF (SENT)
- Previous Close
21.20 - Open
21.17 - Bid --
- Ask 33.96 x 1200
- Day's Range
21.22 - 21.22 - 52 Week Range
21.10 - 25.07 - Volume
1,800 - Avg. Volume
17,193 - Net Assets 3.55M
- NAV 20.86
- PE Ratio (TTM) 13.22
- Yield 0.00%
- YTD Daily Total Return -6.03%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 1.01%
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in U.S. exchange listed equity securities, primarily consisting of common stock of large-, mid-, and small-capitalization U.S. companies, while hedging overall market exposure. Under normal circumstances, it invests at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities. The fund's investments focus on growth-oriented market sectors.
AdvisorShares
Fund Family
Long-Short Equity
Fund Category
3.55M
Net Assets
2021-02-02
Inception Date
Performance Overview: SENT
View MoreTrailing returns as of 11/2/2023. Category is Long-Short Equity.
Holdings: SENT
View MoreTop 9 Holdings (9.42% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: SENT
View MoreCorporate Action: Vote in Favor of Newmont’s Purchase of Newcrest via Scheme of Arrangement
Newmont is the world's largest gold miner, producing about 6 million attributable ounces of gold in 2022, good for about 5% of global mined output. The company also produced 1.3 million attributable gold equivalent ounces from the sale of byproducts, including copper, silver, zinc, and lead in 2022. It had about two decades of gold reserves along with significant byproduct reserves at end 2022. After buying Goldcorp in 2019 and combining its Nevada mines in a joint venture with competitor Barrick later that year, Newmont’s portfolio includes 12 wholly owned mines and interests in two joint ventures in the Americas, Africa, and Australia.
RatingPrice TargetWhat does Argus have to say about KGC?
KINROSS GOLD CORP has an Investment Rating of SELL; a target price of $4.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetAdobe Earnings: Creative Cloud Drives Strength While Firefly AI Begins To Produce Revenue
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing and engaging with compelling content multiple operating systems, devices and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
RatingPrice TargetJohnson & Johnson: Split Off of Consumer Unit Kenvue Likely Final Step in Unit’s Divestment
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
RatingPrice Target